
Chemours Faces Class Action Lawsuit Over Opteon Sales Disclosures
A federal securities class action has been filed against The Chemours Company, alleging the firm misled investors by inflating demand projections for its Opteon refrigerant line. The litigation follows a sharp stock price decline in August 2026, when the company drastically revised its financial outlook for the fiscal year.
























